Market Movers

Molina Healthcare, Inc.’s stock price takes a dip to $313.81, marking a 5.48% decrease: Is it time to buy?

Molina Healthcare, Inc. (MOH)

313.81 USD -18.19 (-5.48%) Volume: 1.48M

Molina Healthcare, Inc.’s stock price currently stands at 313.81 USD, experiencing a decrease of -5.48% this trading session with a trading volume of 1.48M, yet showing a positive year-to-date performance with a percentage change of +7.82%, reflecting the volatile yet promising nature of MOH’s stock market journey.


Latest developments on Molina Healthcare, Inc.

Today, Molina Healthcare (MOH) stock is experiencing a decline after reporting mixed Q1 earnings and a cautious outlook amidst concerns about medical loss ratios and uncertainties surrounding Medicaid rates. Despite this, Molina Healthcare remains focused on Medicaid growth, reaffirming its $42 billion revenue guidance for 2025. The company’s recent acquisition opportunities and strong earnings beat in Q1, driven by growing premiums, have provided some stability. With initiatives like opening One Stop Help Centers in California and providing free healthcare services through mobile clinics, Molina Healthcare is striving to thrive in the ever-changing healthcare market. Analysts at Bernstein have even raised the stock rating to Outperform, indicating a 28% upside potential for investors.


Molina Healthcare, Inc. on Smartkarma

Analysts on Smartkarma have been closely covering Molina Healthcare‘s performance, highlighting both challenges and growth prospects. Baptista Research‘s report on the company’s fourth-quarter and full-year 2024 results showed a mixed picture, with an adjusted EPS of $5.05 for the fourth quarter and $22.65 for the full year, representing an 8.5% year-over-year growth. However, higher-than-anticipated medical costs in the Medicaid and Medicare segments led to a consolidated medical care ratio (MCR) of 90.2% for the quarter, which was above forecasts.

Value Investors Club also provided insights on Molina Healthcare‘s successful business model in the Managed Medicaid market. The company operates in a competitive landscape, offering Managed Medicaid services to low-income individuals on behalf of state governments. With a fixed fee per member, Molina effectively manages Medicaid programs while minimizing risk for state administrators. This analysis showcases the company’s advantage in the industry when states put their programs out to bid.


A look at Molina Healthcare, Inc. Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth4
Resilience4
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Molina Healthcare has a positive long-term outlook. With high scores in Growth, Resilience, and Momentum, the company shows promise for future expansion and stability. This is supported by its strong presence in various states and its focus on providing healthcare services to low-income families.

Although Molina Healthcare may not be the top choice for investors looking for dividends, its overall value is decent. The company’s ability to adapt to market changes and its consistent growth and momentum make it a favorable choice for those seeking long-term investment opportunities in the healthcare sector.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars